Shannon Awrey

1.0k total citations
29 papers, 773 citations indexed

About

Shannon Awrey is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shannon Awrey has authored 29 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shannon Awrey's work include Bladder and Urothelial Cancer Treatments (10 papers), Enzyme function and inhibition (6 papers) and Epigenetics and DNA Methylation (5 papers). Shannon Awrey is often cited by papers focused on Bladder and Urothelial Cancer Treatments (10 papers), Enzyme function and inhibition (6 papers) and Epigenetics and DNA Methylation (5 papers). Shannon Awrey collaborates with scholars based in Canada, United States and Japan. Shannon Awrey's co-authors include Peter C. Black, Shoukat Dedhar, Paul C. McDonald, Wolfgang Jäger, Oksana Nemirovsky, Kilian M. Gust, Tetsutaro Hayashi, Ladan Fazli, Alexander W. Wyatt and Wells S. Brown and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Shannon Awrey

27 papers receiving 764 citations

Peers

Countries citing papers authored by Shannon Awrey

Since Specialization

Citations

This map shows the geographic impact of Shannon Awrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shannon Awrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shannon Awrey more than expected).

Fields of papers citing papers by Shannon Awrey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shannon Awrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shannon Awrey. The network helps show where Shannon Awrey may publish in the future.

Co-authorship network of co-authors of Shannon Awrey

This figure shows the co-authorship network connecting the top 25 collaborators of Shannon Awrey. A scholar is included among the top collaborators of Shannon Awrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shannon Awrey. Shannon Awrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Drug tolerance and persistence to EGFR inhibitor treatment are mediated by an ILK-SFK-YAP signaling axis in lung adenocarcinoma 2025 ·Oncogene ·Rocky Shi, (unknown), Christopher A. Febres‐Aldana, (unknown), (unknown), (unknown), Juan Luis Gomez Marti, (unknown), (unknown), (unknown), Shannon Awrey, Paul C. McDonald, Romel Somwar, Shoukat Dedhar, Marc Ladanyi, Kevin L. Bennewith, William W. Lockwood	0
2	Dual inhibition of carbonic anhydrase IX and glutathione peroxidase 4 as a novel strategy for ferroptosis-induced tumor cell death 2025 ·European Journal of Medicinal Chemistry ·(unknown), Paul C. McDonald, Shannon Awrey, (unknown), (unknown), Michael P. A. Lyle, Zaihui Zhang, Marta Ferraroni, Shoukat Dedhar, (unknown), Andrea Angeli	0
3	Neutrophil extracellular trap gene expression signatures identify prognostic and targetable signaling axes for inhibiting pancreatic tumour metastasis 2025 ·Communications Biology ·Paul C. McDonald, James T. Topham, Shannon Awrey, (unknown), (unknown), Wells S. Brown, Zachary J. Gerbec, Steve E. Kalloger, Joanna M. Karasinska, Patricia A. Tang, Rachel Goodwin, Steven J.M. Jones, Janessa Laskin, Marco A. Marra, Gregg B. Morin, Daniel J. Renouf, David F. Schaeffer, Shoukat Dedhar	2
4	Identification of intratumoral bacteria that enhance breast tumor metastasis 2025 ·mBio ·Zachary J. Gerbec, Antonio Serapio-Palacios, (unknown), (unknown), Haggai Bar‐Yoseph, Sarah E. Woodward, (unknown), Oksana Nemirovsky, Shannon Awrey, (unknown), (unknown), Esther Kong, Nina Radisavljevic, Mihai Cîrstea, Shawn C. Chafe, Paul C. McDonald, Samuel Aparício, B. Brett Finlay, Shoukat Dedhar	4
5	A Carbonic Anhydrase IX/SLC1A5 Axis Regulates Glutamine Metabolism Dependent Ferroptosis in Hypoxic Tumor Cells 2023 ·Molecular Cancer Therapeutics ·Geetha Venkateswaran, Paul C. McDonald, Shawn C. Chafe, Wells S. Brown, Zachary J. Gerbec, Shannon Awrey, (unknown), Shoukat Dedhar	19
6	A Carbonic Anhydrase IX/SLC1A5 Axis Regulates Glutamine Metabolism Dependent Ferroptosis in Hypoxic Tumor Cells 2022 ·SSRN Electronic Journal ·Geetha Venkateswaran, Shawn C. Chafe, Wells S. Brown, Zachary J. Gerbec, Paul C. McDonald, Shannon Awrey, Seth J. Parker, Shoukat Dedhar	3
7	Genome-wide synthetic lethal screen unveils novel CAIX-NFS1/xCT axis as a targetable vulnerability in hypoxic solid tumors 2021 ·Science Advances ·Shawn C. Chafe, Frederick S. Vizeacoumar, Geetha Venkateswaran, Oksana Nemirovsky, Shannon Awrey, Wells S. Brown, Paul C. McDonald, Fabrizio Carta, Andrew Metcalfe, Joanna M. Karasinska, Ling Huang, Senthil K. Muthuswamy, David F. Schaeffer, Daniel J. Renouf, Claudiu T. Supuran, Franco J. Vizeacoumar, Shoukat Dedhar	98
8	Overcoming Adaptive Resistance to KRAS and MEK Inhibitors by Co-targeting mTORC1/2 Complexes in Pancreatic Cancer 2020 ·Cell Reports Medicine ·Wells S. Brown, Paul C. McDonald, Oksana Nemirovsky, Shannon Awrey, Shawn C. Chafe, David F. Schaeffer, Jinyang Li, Daniel J. Renouf, Ben Z. Stanger, Shoukat Dedhar	74
9	Harnessing Induced Essentiality: Targeting Carbonic Anhydrase IX and Angiogenesis Reduces Lung Metastasis of Triple Negative Breast Cancer Xenografts 2019 ·Cancers ·Eva–Maria Hedlund, Paul C. McDonald, Oksana Nemirovsky, Shannon Awrey, Lasse D. Jensen, Shoukat Dedhar	38
10	Not all NOTCH Is Created Equal: The Oncogenic Role of NOTCH2 in Bladder Cancer and Its Implications for Targeted Therapy 2016 ·Clinical Cancer Research ·Tetsutaro Hayashi, Kilian M. Gust, Alexander W. Wyatt, (unknown), Wolfgang Jäger, Shannon Awrey, Na Li, Htoo Zarni Oo, Manuel Altamirano-Dimas, Ralph Buttyan, Ladan Fazli, Akio Matsubara, Peter C. Black	75
11	Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients 2016 ·Genome biology ·Nada Lallous, Stanislav Volik, Shannon Awrey, Eric Leblanc, (unknown), (unknown), Kriti Singh, Arun Azad, Alexander W. Wyatt, Stéphane LeBihan, Kim N., Martin Gleave, Paul S. Rennie, Colin C. Collins, Artem Cherkasov	154
12	Targeting Binding Function-3 of the Androgen Receptor Blocks Its Co-Chaperone Interactions, Nuclear Translocation, and Activation 2016 ·Molecular Cancer Therapeutics ·Nada Lallous, Eric Leblanc, (unknown), Mohamed D.H. Hassona, Nader Al Nakouzi, Shannon Awrey, Hélène Morin, Mani Roshan‐Moniri, Kriti Singh, (unknown), Takeshi Yamazaki, Hans Adomat, (unknown), Mads Daugaard, Robert N. Young, Emma S. Tomlinson Guns, Paul S. Rennie, Artem Cherkasov	25
13	Targeting HER2 with T-DM1, an Antibody Cytotoxic Drug Conjugate, is Effective in HER2 Over Expressing Bladder Cancer 2015 ·The Journal of Urology ·Tetsutaro Hayashi, Roland Seiler, Htoo Zarni Oo, Wolfgang Jäger, Igor Moskalev, Shannon Awrey, Takashi Dejima, Tilman Todenhöfer, Na Li, Ladan Fazli, Akio Matsubara, Peter C. Black	70
14	Minimally Invasive Establishment of Murine Orthotopic Bladder Xenografts 2014 ·Journal of Visualized Experiments ·Wolfgang Jäger, Igor Moskalev, (unknown), Tetsutaro Hayashi, (unknown), Shannon Awrey, Peter C. Black	13
15	NOTCH2 inhibition on tumor growth and metastasis in bladder cancer. 2014 ·Journal of Clinical Oncology ·Tetsutaro Hayashi, Kilian M. Gust, Wolfgang Jäeger, Shannon Awrey, Na Li, Manuel Altamirano-Dimas, Ralph Buttyan, Ladan Fazli, Akio Matsubara, Peter C. Black	2
16	Ultrasound-Guided Intramural Inoculation of Orthotopic Bladder Cancer Xenografts: A Novel High-Precision Approach 2013 ·PLoS ONE ·Wolfgang Jäger, Igor Moskalev, (unknown), Tetsutaro Hayashi, Shannon Awrey, Kilian M. Gust, Alan So, Kaixin Zhang, Ladan Fazli, Estelle Li, Joachim W. Thüroff, Dirk Lange, Peter C. Black	42
17	594 SPECIFIC INHIBITON OF NOTCH-2 AS A NOVEL THERAPY FOR INVASIVE BLADDER CANCER 2013 ·The Journal of Urology ·Tetsutaro Hayashi, Kilian M. Gust, Wolfgang Jäeger, Shannon Awrey, Na Li, Manuel Altamirano-Dimas, Ralph Buttyan, Estelle Li, Ladan Fazli, Peter C. Black	2
18	Hiding in Plain View: Genetic Profiling Reveals Decades Old Cross Contamination of Bladder Cancer Cell Line KU7 with HeLa 2013 ·The Journal of Urology ·Wolfgang Jäger, Yutaka Horiguchi, Jay B. Shah, Tetsutaro Hayashi, Shannon Awrey, Kilian M. Gust, Boris Hadaschik, Yoshiyuki Matsui, Shawn Anderson, Robert H. Bell, Susan Ettinger, Alan So, Martin Gleave, I-Ling Lee, Colin P. Dinney, Masaaki Tachibana, David J. McConkey, Peter C. Black	25
19	Fibroblast Growth Factor Receptor 3 Is a Rational Therapeutic Target in Bladder Cancer 2013 ·Molecular Cancer Therapeutics ·Kilian M. Gust, David J. McConkey, Shannon Awrey, Paul K. Hegarty, Jing Qing, Jolanta Bondaruk, Avi Ashkenazi, Bogdan Czerniak, Colin P. Dinney, Peter C. Black	77
20	Intrinsic resistance of prostate cancer to the BH3 mimetic ABT-737 is related to expression of the anti-apoptotic Mcl-1 and additional survival and apoptosis regulating pathways 2007 ·Molecular Cancer Therapeutics ·Jorg Michels, (unknown), (unknown), Shannon Awrey, Martin Gleave	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact